The application of sartans in hypertension drugs is very wide, such as Irbesartan, Valsartan and Crosartan have a good antihypertensive effect, and the application of these drugs in people with mild renal insufficiency can help improve urinary protein and renal function, and the application of these drugs in people with cardiac insufficiency and heart failure can also help improve ventricular remodeling, which can improve the prognosis of patients with heart failure. For these drugs, patients can choose to apply them to stabilize their blood pressure within the standard range. Most of these drugs will achieve maximum blood pressure lowering effect in 2-3 weeks, but there are certain groups of people who do not tolerate these drugs, such as some people who tend to have increased blood potassium, so they are not recommended for such patients.